U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07628972) titled 'Quercetin Dyskeratosis Congenita (DC)/Telomere Biology Disorders (TBD)' on June 01.
Brief Summary: The purpose of this study is to see if a vitamin-like substance called quercetin is safe for people who have a rare condition called Dyskeratosis congenita (DC) or telomere biology disorders (TBD).
Study Start Date: May 29
Study Type: INTERVENTIONAL
Condition:
Dyskeratosis Congenita
Telomere Disease
Intervention:
DRUG: Quercetin
Quercetin (3, 30, 40, 5, 7-pentahydroxyflavone) is a naturally occurring antioxidant that belongs to a group of polyphenolic compounds known as flavonoids. Quercetin is routinely available as an over-the-...